During the last session, Neuphoria Therapeutics Inc (NASDAQ:NEUP)’s traded shares were 2.96 million, with the beta value of the company hitting 0.40. At the end of the trading day, the stock’s price was $4.63, reflecting an intraday gain of 3.58% or $0.16. The 52-week high for the NEUP share is $16.08, that puts it down -247.3 from that peak though still a striking 54.21% gain since the share price plummeted to a 52-week low of $2.12. The company’s market capitalization is $5.37M, and the average intraday trading volume over the past 10 days was 0.19 million shares, and the average trade volume was 566.54K shares over the past three months.

Neuphoria Therapeutics Inc (NASDAQ:NEUP) trade information

Neuphoria Therapeutics Inc (NEUP) registered a 3.58% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.58% in intraday trading to $4.63, hitting a weekly high. The stock’s 5-day price performance is -10.10%, and it has moved by 46.52% in 30 days. Based on these gigs, the overall price performance for the year is -60.31%.

Neuphoria Therapeutics Inc (NEUP) estimates and forecasts

In the rating firms’ projections, revenue will increase 25.38% compared to the previous financial year.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 14.52%. While earnings are projected to return 92.79% in 2025, the next five years will return 61.75% per annum.

NEUP Dividends

Neuphoria Therapeutics Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.